Sign in / Sign up

← Back to investors

Mirae Asset Securities Co., Ltd.

证券机构

Verified investment lower bound≥$20.33M

Investment cases2

Manager operating history—

Representative investments

MiniMax$7.16B Insilico Medicine（英矽智能）$2.65B

Search

#	Company	Market cap / valuationUSD	Total fundingUSD	Last financing / listing	Key investors
28	MiniMax0100.HK · 中国	$7.16BMarket capitalizationMarket date not provided Sources · 1 MiniMax Group Inc. ↗2026-10-22	≥$1.56BVerified lower bound	IPO / listing2026-01-09	Alibaba miHoYo IDG Capital Tencent Hillhouse HongShan Other investors · 20 Shunwei Capital MPC VII Pte. Ltd. Future Capital Pacific Century Group Abu Dhabi Investment Authority（ADIA） Aspex Management (HK) Limited Boyu Capital Management (Singapore) Pte. Ltd.（博裕） China Universal Asset Management (Hong Kong)（汇添富香港） Eastspring Investments (Singapore) E Fund Management（易方达基金） IDG Breyer Capital Fund L.P. Janchor Partners Limited（健瓴投资） Pulsating Star GP Limited Mirae Asset Securities Co., Ltd. Perseverance Asset Management International (Singapore) Pte. Ltd. Taikang Life Insurance（泰康人寿） Bosera Asset Management (International)（博时国际） China Asset Management（华夏基金） ICBC UBS Asset Management (International)（工银瑞信国际） CITIC Securities Asset Management（中信证券资管）
55	Insilico Medicine（英矽智能）3696.HK · 美国/中国	$2.65BMarket capitalizationMarket date not provided Sources · 1 Insilico Medicine Lists on Hong Kong Stock Exchange, Showing AI Drug Discovery Momentum with 2025's Largest Hong Kong Biotech IPO ↗2026-10-22	≥$110MVerified lower bound	IPO / listing2025-12-30	Value Partners PE Fund Eli Lilly Tencent Oaktree Capital Management Schroders（施罗德） Temasek Other investors · 14 UBS China Asset Management（华夏基金） Pacific Asset Management（太平洋资产） CPIC Investment Management HK E Fund Management（易方达基金） Fullgoal Fund Management（富国基金） Harvest Global Investments（嘉实国际） Taikang Life Insurance（泰康人寿） RTW Investments Exome Asset Management Infini Capital Management（无极资本） Capital Group Mirae Asset Securities Co., Ltd. OrbiMed Advisors IV Limited